The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis product

Cytotherapy

Volumn 1, Issue 2, 1999, Pages 141-146

  Hollingsworth, K L ^a   Zimmerman, T M ^a   Karrison, T ^a   Oliver, A ^a   Williams, S F ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

CD34 cell enumeration; Flow cytometry; Leukapheresis; Stem cell

Indexed keywords

EID: 0000199665     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/0032472031000141252     Document Type: Article

References (19)

1. Williams SF, Zimmerman T, Grad G et al. Source of stem cell rescue: bone marrow versus peripheral blood products. J Hematother 1993;2:521-3.
2. Champlin RE. Peripheral blood progenitor cells: a replacement for marrow transplantation? Semin Oncol 1996;23:15-21.
3. Hill GR, Inder A, Patton WN et al. High dose therapy and autologous bone marrow versus blood cell rescue. N Z Med J 1996;109:45-8.
4. + cells from an HLA-identical unrelated donor. Bone Marrow Transplant 1995;16:719-22.
5. Myers SE, Mick R, Williams SE High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant. Bone Marrow Transplant 1994;13:449-54.
6. Anderson KC. Autologous peripheral blood progenitor cell transplantation. J Clin Apheresis 1995;10:131-8.
7. Handelsman H. Autologous peripheral stem cell transplantation. Health Technol Assess 1995;5:1-16.
8. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86:3961-9.
9. Schwella N, Siegert W, Beyer J et al. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cells dose with hematopoietic reconstitution. Ann Hematol 1995;71:227-34.
10. Zimmerman TM, Lee WJ, Bender JG a al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995;15:439-44.
11. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995;13:2547-55.
12. Zeger SL, Liang KY Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-21.
13. Davis CS. A computer program for regression analysis of repeated measures using generalized estimating equations. Comput Methods Programs Biomed 1993 ;40:15-31.
14. Schwella N, Beyer J, Schwaner I et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996;14:1114-21.
15. Elliott C, Samson DM, Armitage S et al. When to harvest peripheral blood stem cells after mobilization therapy: prediction of CD34positive cell yield by preceding day CD34-positive concentration in peripheral blood. Clin Oncol 1996; 14:970-3.
16. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-15.
17. Moskowitz CH, Glassman JR, Wuest D et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 1998;4(2):311-6.
18. Richman CM, Schuermann TC, Won T et al. Peripheral blood stem cell mobilization for hematopoietic support of radio-immunotherapy in patients with breast carcinoma. Cancer 1997;80(12 Suppl): 2728-32.
19. + mononuclear cell counts as predictors of progenitor cell yield. Transfusion 1997;37:79-85